Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization and clinical relevance of PDGFRA pathway copy number variation gains across human cancers.

Molecular genetics and genomics : MGG - 1 Mar 2022

Liu Lizhu, Wu Lihong, Shan Dan, Han Bo

Abstract excerpt

We investigated the copy number variation (CNV) of PDGFRA pathway across all common cancer types as well as its clinical relevance. This study included a total of 10,678 patients with pan-cancerous species involving 33 types of cancers and patient information was obtained from The Cancer Genome Atlas. According to the PDGFRA pathway CNV, all samples were divided into copy number gain (CN gain) group and No CN...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Copy Number Variations
Share to Genome
Share to Loss of Heterozygosity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35212838
DOI: 10.1007/s00438-022-01860-y
PMCID: PMC8960564

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization and clinical relevance of PDGFRA pathway copy number variation gains across human cancers.PMID 35212838Read ↗

PDGFRA amplification could be a poor prognostic factor of advanced undifferentiated pleomorphic sarcoma in a comprehensive genomic profiling cohortSemantic proximity Read ↗

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy TargetsSemantic proximity Read ↗

Systematic screening identifies a 2‐gene signature as a high‐potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcomaSemantic proximity Read ↗

PDGFRA alterations in cancer: characterization of a gain-of-function V536E transmembrane mutant as well as loss-of-function and passenger mutationsSemantic proximity Read ↗

Prevalence, clinico-pathological value, and co-occurrence of PDGFRA abnormalities in diffuse gliomas.Semantic proximity Read ↗

Concordance between somatic copy number loss and down-regulated expression: A pan-cancer study of cancer predisposition genes.Semantic proximity Read ↗

Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation.Semantic proximity Read ↗

miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs.Semantic proximity Read ↗

New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategiesSemantic proximity Read ↗

Transcriptome analysis of PDGFRα+ cells identifies T-type Ca2+ channel CACNA1G as a new pathological marker for PDGFRα+ cell hyperplasiaSemantic proximity Read ↗

The role of PDGFRA as a therapeutic target in young colorectal cancer patientsSemantic proximity Read ↗

Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.